Dennis K. Stone
Corporate Officer/Principal chez American Society for Clinical Investigation
Profil
Dennis K.
Stone is a member of the Association of American Physicians and the American Society for Clinical Investigation.
He previously served as Vice Chairman-Life Science Commercialization at Texas Emerging Technology Fund, Director at Gilead Colorado, Inc., Independent Director at Bellicum Pharmaceuticals, Inc., Director at miRagen Therapeutics, Inc., Director at MacroGenics, Inc., Director at Eliance Biotechnology, Inc., Vice President-Technology Development and Professor at The University of Texas Southwestern Medical Center, and Chief Scientific Officer at Remeditex Ventures LLC.
He holds an undergraduate degree from The University of Texas at Austin and a doctorate from The University of Texas Southwestern Medical Center.
Currently, he holds positions as a member of the Association of American Physicians and the American Society for Clinical Investigation.
Postes actifs de Dennis K. Stone
| Sociétés | Poste | Début |
|---|---|---|
American Society for Clinical Investigation
 American Society for Clinical Investigation BiotechnologyHealth Technology American Society for Clinical Investigation engages as a medical honor society. It focuses on physician-scientists in research, clinical care, and medical education. The company was founded by Samuel J. Meltzer in 1908 and is headquartered in Ann Arbor, MI. | Corporate Officer/Principal | 24/02/2010 |
Association of American Physicians
 Association of American Physicians Miscellaneous Commercial ServicesCommercial Services The Association of American Physicians operates as an American association of physicians. The non-profit company is based in Tucson, AZ. The company was founded by Charles Lee. | Corporate Officer/Principal | 24/02/2010 |
Anciens postes connus de Dennis K. Stone
| Sociétés | Poste | Fin |
|---|---|---|
| REATA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/03/2017 |
| The University of Texas Southwestern Medical Center | Directeur Technique/Scientifique/R&D | 01/07/2011 |
Remeditex Ventures LLC
 Remeditex Ventures LLC Investment ManagersFinance Remeditex Ventures LLC (Remeditex Ventures) is a venture capital firm founded in 2011. The firm is headquartered in Dallas, Texas. | Directeur Technique/Scientifique/R&D | - |
Texas Emerging Technology Fund
 Texas Emerging Technology Fund Investment Trusts/Mutual FundsMiscellaneous Texas Emerging Technology Fund provides technology investment fund. It offers funds in the form of equity, convertible debt, grants, and other forms of contribution or investment. The company was founded in 2005 and is headquartered in College Station, TX. | Corporate Officer/Principal | - |
| The University of Texas Southwestern Medical Center | Corporate Officer/Principal | - |
Formation de Dennis K. Stone
| The University of Texas Southwestern Medical Center | Doctorate Degree |
| The University of Texas at Austin | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MACROGENICS, INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology American Society for Clinical Investigation engages as a medical honor society. It focuses on physician-scientists in research, clinical care, and medical education. The company was founded by Samuel J. Meltzer in 1908 and is headquartered in Ann Arbor, MI. | Health Technology |
Association of American Physicians
Association of American Physicians Miscellaneous Commercial ServicesCommercial Services The Association of American Physicians operates as an American association of physicians. The non-profit company is based in Tucson, AZ. The company was founded by Charles Lee. | Commercial Services |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
Eliance Biotechnology, Inc.
 Eliance Biotechnology, Inc. BiotechnologyHealth Technology Part of MacroGenics, Inc., Eliance Biotechnology, Inc. is a company that researches and develops vaccines. The company is based in Dallas, TX. The company was founded by Stephen Albert Johnston. Eliance Biotechnology was acquired by MacroGenics, Inc. on June 07, 2002. | Health Technology |
Gilead Colorado, Inc.
 Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | Health Technology |
miRagen Therapeutics, Inc. /Old/
 miRagen Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology miRagen Therapeutics, Inc. develops microRNA-based therapeutics for cardiovascular and muscle diseases. It leverages in-house expertise in miRNA biology, oligonucleotide chemistry, and drug development to evaluate and advance RNA-based technologies and potential drug candidates for its own pipeline and in strategic collaborations. The firm aso focuses on hematological malignancies, fibrosis and neuro inflammation. The company was founded by William S. Marshall, Michael R. Bristow, Marvin H. Caruthers, Bruce Lee Booth and Eric Newell Olson in 2007 and is headquartered in Boulder, CO. | Health Technology |
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
Texas Emerging Technology Fund
Texas Emerging Technology Fund Investment Trusts/Mutual FundsMiscellaneous Texas Emerging Technology Fund provides technology investment fund. It offers funds in the form of equity, convertible debt, grants, and other forms of contribution or investment. The company was founded in 2005 and is headquartered in College Station, TX. | Miscellaneous |
Remeditex Ventures LLC
Remeditex Ventures LLC Investment ManagersFinance Remeditex Ventures LLC (Remeditex Ventures) is a venture capital firm founded in 2011. The firm is headquartered in Dallas, Texas. | Finance |
